Fatty15 is a daily supplement built around a single ingredient: pure pentadecanoic acid (C15), a saturated odd-chain fatty acid found naturally in small amounts in full-fat dairy and ruminant fat. The company behind it, Epitracker, argues that C15 is an ‘essential’ fatty acid that modern low-fat diets have stripped from our plates, and that supplementing it may support cell membrane stability, metabolic signaling, and healthy aging. Bold claims for a single fatty acid, but unlike many supplements, there is at least a growing body of peer-reviewed research to examine.
Fatty15 discount code: SFKKDBQQ takes 20% off at fatty15.com (minimum $20 order). Open Fatty15 with the 20% discount. We earn a commission if you buy through this link, at no extra cost to you.
This review covers what C15 actually is, the proposed mechanisms, what the published evidence says, where the evidence is still thin, and whether the price tag is reasonable given what we currently know. No cures are claimed here and nothing in this article constitutes medical advice. The FDA has not evaluated C15 supplements for the treatment or prevention of any disease.
Key Takeaways
- C15 is a real fatty acid found in full-fat dairy with genuinely interesting preliminary research behind it, but large, independent human trials are still lacking.
- The proposed mechanisms (membrane stabilization, PPAR-alpha/delta partial agonism, ferroptosis resistance) are biologically plausible but not yet clinically established in humans at supplemental doses.
- In the one small randomized trial of C15 alone (200 mg a day for 12 weeks), no significant adverse events were reported; long-term safety data is limited [5].
- The ‘essential fatty acid’ classification for C15 is a hypothesis from Epitracker researchers, not a formal regulatory or mainstream scientific consensus.
- For dairy consumers, food sources may supply some C15 at far lower cost, though in one feeding trial daily dairy servings raised blood C15 only slightly, so the two are hard to compare; the supplement case is strongest for those who have substantially eliminated dairy from their diet [15][16].
What Is C15 and Where Does It Come From?
Pentadecanoic acid is a 15-carbon saturated fatty acid. Unlike the more familiar even-chain saturated fats (like palmitic acid at C16:0), odd-chain saturated fatty acids have a distinct metabolic fate in the body. C15 is found primarily in the fat of ruminant animals: beef, lamb, and especially dairy products like whole milk, butter, and cheese.[1] Dietary intake is a main source, but the body can also make some, for example from gut-derived propionic acid, so blood levels are not purely a dairy marker [7][1][8][9].[2]
Epitracker researchers argue that as Western diets shifted toward low-fat dairy and leaner proteins over the past few decades, average C15 intake declined. Epitracker researchers have hypothesized that this decline may have unintended consequences for cellular health, framing C15 as conditionally or newly essential: a classification that has not been formally adopted by the FDA, EFSA, or mainstream nutrition bodies. The ‘essential’ label remains a hypothesis advanced by the supplement’s developers, not a settled scientific consensus.
Proposed Mechanisms: How C15 Is Supposed to Work
Epitracker researchers propose several biological mechanisms for C15. First, because odd-chain fatty acids have different packing geometry than even-chain fats, C15 is thought to integrate into cell membranes in a way that increases their stability and reduces fragility. Cells with more fragile membranes are believed to be more susceptible to a form of cell death called ferroptosis, and early research has explored whether C15 supplementation might reduce this vulnerability.[3]
Research note: In the umbrella review’s evidence grading, C15:0 reached only suggestive (class III) credibility, not strong or convincing [21].
Second, C15 has been studied as a partial agonist of PPAR-alpha and PPAR-delta: nuclear receptors that regulate fatty acid oxidation, inflammation, and metabolic function.[4] Partial agonism is a nuanced pharmacological concept: unlike a full agonist, a partial agonist activates a receptor to a submaximal degree, which can sometimes translate to a more favorable side-effect profile, though this has not been definitively established for C15 in humans.
Third, some early research has explored a potential relationship between C15 and cellular senescence: the state where aging cells stop dividing but remain metabolically active and can promote inflammation in surrounding tissue. These mechanisms are biologically plausible and have generated genuine scientific interest, but most supporting data comes from cell studies, animal models, or small human observational work. Large randomized controlled trials in humans are still limited.
What Does the Published Evidence Actually Show?
The research base for C15 is newer and narrower than the marketing around Fatty15 sometimes implies. Observational studies have linked higher circulating C15 levels to lower type 2 diabetes risk in prospective cohorts, but links to cardiovascular disease are inconsistent: plasma C15 was not associated with incident cardiovascular disease in the CARDIA and ARIC cohorts [10][11][12][13]. Associations, however, do not establish causation: people who consume more full-fat dairy also differ from low-fat dairy consumers in many other dietary and lifestyle ways.
The Epitracker team has published preclinical and some early clinical work showing that purified C15 (the same form in Fatty15) can raise circulating C15 levels and demonstrated activity at PPAR receptors and in cell-based ferroptosis models. These findings are genuinely interesting and have been peer-reviewed, but the sample sizes are small and the studies are largely conducted or co-authored by the researchers who developed and sell the supplement: a conflict of interest that is common in early-stage nutrition science but worth noting when weighing the evidence.
No large, independent, long-term randomized controlled trials of C15 supplementation have been published to date. The current evidence is best described as promising and hypothesis-generating rather than conclusive. Anyone buying Fatty15 is essentially an early adopter of a supplement whose full clinical picture is still being written.
Does Fatty15 Work? What the Two Trials Measured
“Working” can mean three different things: raising blood C15, changing a health marker, or making you feel different. The controlled evidence covers the first two only.
What the 12-week Fatty15 trial measured, step by step
30 young adults
Mean age 20, with overweight or obesity.
200 mg C15:0 or placebo
Daily for 12 weeks, double-blind.
+1.88 µg/mL vs placebo
C15:0 in blood rose more than on placebo.
Only GGT changed
The liver enzyme GGT fell 11 U/L versus placebo; no other secondary outcome changed.
Maker-supported
Seraphina Therapeutics, the maker of Fatty15, supplied the capsules.
A small, short, industry-supported trial: useful for safety signals, not proof that C15:0 improves health.
Randomized, double-blind, placebo-controlled trial. Source: Robinson et al., The Journal of Nutrition 2024.
Chart: c15hub.com: What the 12-week Fatty15 trial measured, step by step
Embed this chart
Free to reuse on your site. Copy the code below; please keep the credit link.
The first randomized, double-blind trial of C15 on its own gave 200 mg a day or placebo to 30 young adults with overweight or obesity for 12 weeks. Blood C15 rose by 1.88 µg/mL more than on placebo. Participants who finished above 5 µg/mL had larger drops in the liver enzymes ALT and AST and a larger rise in hemoglobin, an observation the authors say warrants further study. It came from a post-hoc subgroup of C15 takers, and apart from a drop in the liver enzyme GGT the trial found no other significant changes versus placebo [5].[5]
The TANGO trial tested C15 alongside a Mediterranean-style diet in women with fatty liver disease. Most of the improvement came from the diet itself; see C15 and liver health for the details.[6] Neither trial measured sleep, mood or energy, which are the effects most often described in customer reviews. For a fuller walk-through of the research, see how the C15 trials were designed.
Safety and Tolerability
In the one randomized trial of C15 on its own, 200 mg a day for 12 weeks produced no significant adverse events.[5] That is a small, short study, so it supports tolerability in that group rather than long-term safety for everyone. The trial reported no significant adverse events. The only side effects mentioned come from the company, which says constipation, diarrhea or headache occur in under 0.1% of customers [5][14].
That said, long-term safety data beyond the timeframes of published trials is not yet available. People with known liver conditions, lipid metabolism disorders, or who are pregnant or breastfeeding should consult a physician before adding any fatty acid supplement. Because C15 affects PPAR pathways that also regulate lipid metabolism, individuals on medications that interact with these pathways, such as fibrates used for high triglycerides, should seek medical guidance.
Pregnancy is a specific open question. In pregnant mice, a C15-enriched diet caused mild insulin resistance, and in obese pregnant mice it caused mild glucose intolerance. In mother-infant pairs, higher red blood cell C15 was seen in small-for-gestational-age babies, and higher breast-milk C15 was linked to lower infant motor scores in 120 mother-infant pairs. These are animal and observational findings, not proof of harm [17][18][19][20].
Is Fatty15 Worth the Price?
Fatty15 sells its 90-capsule starter kit (100 mg per capsule) as a one-time purchase or at a subscription discount, with refills shipping every 90 days. Per 100 mg it costs several times more than the 300 mg sheep-milk C15:0 capsules we compared, and the brand suggests one or two capsules a day. For a single-ingredient supplement with a limited trial record, that is a premium price. Fatty15 describes its C15 as pure and patented; it does not extract it from dairy fat. Other C15 capsules cost far less per milligram, which we compare in our guide to Fatty15 alternatives.
Whether that justifies the cost depends heavily on your personal situation. If you regularly consume full-fat dairy, your baseline C15 intake may already be meaningful, and the marginal benefit of supplementing is less clear. If you follow a vegan or very low-fat diet, or have reduced dairy substantially, the argument for supplementation is at least internally coherent given the proposed mechanisms. People optimizing for every marginal health variable and willing to pay for early-stage research will find more to like here than those seeking proven, large-effect interventions.
It is worth noting that the natural food alternative, consuming a moderate amount of full-fat dairy, provides C15 alongside a broad matrix of other nutrients (calcium, vitamin K2, protein) and costs far less. For most people who tolerate dairy, improving dietary C15 through food may be a reasonable first step before considering a dedicated supplement.
Is Fatty15 Legit?
Yes, in the sense that matters for a purchase: it is a real company selling a real, single ingredient. Pentadecanoic acid is a well-characterized fatty acid found in dairy fat, and Fatty15 lists its contact details ([email protected] and a phone number) on its site. The fair skepticism is about the evidence, not the product. Much of the research Fatty15 cites was written by people who founded or work for the companies that sell it, and those papers disclose it. The brand’s own product page also notes that some featured users were compensated.
What Customer Reviews Show, and What They Cannot
Ratings depend heavily on where you look. On October 15, 2026:
- fatty15.com: 4.8 stars from 8,572 reviews, with 94% saying they would recommend. The review widget appears to pool several products, and the company runs the platform.
- Trustpilot: a TrustScore of 3.4 from only 45 reviews, with 38% one-star. The complaints we read there were mostly about billing after cancelling and refused refunds rather than about the capsules.
The brand also says 70% of customers report benefits within 16 weeks, based on a survey of 6,243 customers, and that side effects occur in under 0.1% of more than 77,000 customers. We could not find how either figure was collected, and neither has a placebo comparison. Reviews are useful for practical things such as shipping and customer service. They cannot tell you whether C15 caused anyone to feel better, because sleep, mood and energy vary on their own and people who paid for a supplement tend to want it to work.
Subscription, Cancellation and Refunds
Most complaints about Fatty15 are about the subscription, so read these terms, taken from fatty15.com on October 15, 2026, before you subscribe:
- Refunds: a 30-day money-back guarantee applies to first-time trial or starter kit orders only. Refills, renewals, and 6-month and annual kits are not refundable.
- Cancelling: done from your account page under the subscription settings, at least 14 days before the next renewal. You can also change the delivery date or schedule there.
- Renewals: refills ship and bill every 90 days unless you cancel in time.
Because the brand says longer-term effects take months, a 30-day refund window on the first order is short for judging whether it works for you. If you want to try C15 without a subscription, buy a one-time kit and set a reminder before any renewal date.
Who Might Have the Strongest Case for Trying It?
The people with the clearest rationale for considering Fatty15 are those who have eliminated or severely restricted full-fat dairy and ruminant fats (whether due to dietary preference, lactose intolerance, or medical advice) and who are interested in proactively supporting cellular health as they age. In this context, the supplement fills a genuine dietary gap, even if the full clinical evidence for the benefits of filling that gap is still accumulating.
It may also be of interest to individuals whose bloodwork shows markers consistent with metabolic dysfunction and who are exploring adjunctive nutritional support alongside, not instead of, medical care. Anyone in this category should discuss C15 with their prescribing physician, particularly given the PPAR-pathway activity and the potential for interactions with lipid-modifying medications.
🛒 Where to Buy Pentadecanoic Acid (C15)
- Fatty15 (official site) 20% off with code SFKKDBQQ
capsules, 100 mg C15 per capsule; 1 capsule/day starter, 2 capsules/day maintenance: Category creator, from the original Epitracker research team (Venn-Watson et al.); uses a patented, sustainably-sourced pure C15 ingredient; most expensive per-capsule but reference product for all comparisons - Double Wood Supplements Pentadecanoic Acid C15
capsules, 200 mg C15 per serving (2 capsules): Generic C15 supplement; significantly lower price than Fatty15; no independent clinical trials on this specific product; good option for budget-conscious buyers who want to trial the fatty acid - Sports Research Pentadecanoic Acid C15
softgels, 100 mg C15 per softgel: Established supplement brand with strong Amazon presence; softgel form may aid fat-soluble absorption; competitively priced mid-tier option - BulkSupplements Pentadecanoic Acid Powder (C15)
powder, 100 to 300 mg per measured serving: Most economical option for higher-dose protocols or stackers; requires a milligram-accurate scale; no excipients or additives; not recommended for beginners unfamiliar with powder dosing
As an Amazon Associate we earn from qualifying purchases. C15 products vary widely in how much pentadecanoic acid they actually contain, so check that the Supplement Facts panel lists C15 in milligrams as its own line item rather than bundling it into a fatty acid blend, and that the per-serving dose falls in the 100 to 300 mg range used in published research.
A Note on the Evidence
The evidence for C15 supplementation is early-stage, with most human data coming from small studies conducted by researchers with a financial stake in the product; individuals who are pregnant, breastfeeding, have liver or lipid metabolism conditions, or take medications affecting PPAR pathways or lipid levels should consult a physician before using Fatty15 or any C15 supplement.
Want the detail behind the numbers? See the 2024 C15:0 supplement trial, explained and the C15:0 vs omega-3 cell study, explained.
Frequently Asked Questions
What is C15 and why haven't I heard of it before?
C15 (pentadecanoic acid) is a 15-carbon saturated fatty acid naturally present in full-fat dairy and ruminant fat. It received little scientific attention for decades because research focus was on even-chain fatty acids. Epitracker researchers began publishing on its potential health significance around 2020, which is when public awareness started to grow.
Is Fatty15 the same as eating more butter or cheese?
Not exactly. Full-fat dairy contains C15 alongside many other fatty acids, cholesterol, and nutrients. Fatty15 delivers purified C15, which the company argues allows for a consistent, controlled dose without the accompanying saturated fat load. Whether that distinction matters clinically for most people has not been directly compared in trials.
Has the FDA approved Fatty15 or C15 as essential?
No. The FDA has not evaluated C15 supplements for the treatment or prevention of any disease. The claim that C15 is a newly essential fatty acid is a scientific hypothesis put forward by Epitracker researchers and has not been formally adopted by regulatory bodies or mainstream nutrition science.
Are there any known side effects or drug interactions?
The one small randomized trial of C15 alone (200 mg a day for 12 weeks) reported no significant adverse events. Fatty15 says constipation, diarrhea or headache occur in under 0.1% of customers, which is company reporting, not trial data [5][14]. Because C15 has activity at PPAR-alpha and PPAR-delta receptors, there is a theoretical interaction risk with fibrate medications (used for high triglycerides) and other lipid-modifying drugs. Consult your physician if you are on any such medications.
How long does it take to see results with Fatty15?
Published studies measuring circulating C15 levels have generally used supplementation periods of several weeks to a few months to detect changes in red blood cell fatty acid composition. There is no established timeline for any subjective benefit, and the research does not yet support predicting what specific effects an individual will notice or when.
Is Fatty15 a scam?
No. It is a real company selling pentadecanoic acid capsules. The reasonable concerns are that much of the research behind it comes from people tied to the company, that it costs far more per milligram than other C15 products, and that its refund terms are narrow.
Can I get a refund on Fatty15?
On a first-time trial or starter kit, Fatty15 offers a 30-day money-back guarantee. Refills, renewals and 6-month or annual kits are not refundable, according to its refund policy on October 15, 2026.
How do I cancel a Fatty15 subscription?
Through your account page in the subscription settings. Fatty15 asks for cancellation at least 14 days before the next renewal.
Is the research on C15 independent?
Much of the published C15 research has been conducted or co-authored by the Epitracker team, who also developed and sell Fatty15. The studies have been peer-reviewed and published in legitimate journals, but the conflict of interest is worth factoring into how much weight you give the findings. Independent replication by unaffiliated research groups would substantially strengthen the evidence base.
References
- Pfeuffer M, Jaudszus A. Pentadecanoic and Heptadecanoic Acids: Multifaceted Odd-Chain Fatty Acids. Advances in nutrition (Bethesda, Md.). 2016;7(4):730-4. PMID 27422507
- Ciesielski V, Legrand P, Blat S, et al. New insights on pentadecanoic acid with special focus on its controversial essentiality: A mini-review. Biochimie. 2024;227(Pt B):123-129. PMID 39395658
- Venn-Watson S. The Cellular Stability Hypothesis: Evidence of Ferroptosis and Accelerated Aging-Associated Diseases as Newly Identified Nutritional Pentadecanoic Acid (C15:0) Deficiency Syndrome. Metabolites. 2024;14(7). PMID 39057678
- Venn-Watson S, Lumpkin R, Dennis EA. Efficacy of dietary odd-chain saturated fatty acid pentadecanoic acid parallels broad associated health benefits in humans: could it be essential? Scientific reports. 2020;10(1):8161. PMID 32424181
- Robinson MK, Lee E, Ugalde-Nicalo PA, et al. Pentadecanoic Acid Supplementation in Young Adults with Overweight and Obesity: A Randomized Controlled Trial. The Journal of nutrition. 2024;154(9):2763-2771. PMID 39069269
- Chooi YC, Zhang QA, Magkos F, et al. Effect of an Asian-adapted Mediterranean diet and pentadecanoic acid on fatty liver disease: the TANGO randomized controlled trial. The American Journal of Clinical Nutrition. 2024;119(3):788-799. PMID 38035997
- Weitkunat K et al. Odd-chain fatty acids as a biomarker for dietary fiber intake: a novel pathway for endogenous production from propionate. The American journal of clinical nutrition (2017). PMID 28424190
- Weitkunat K et al. Effect of Microbial Status on Hepatic Odd-Chain Fatty Acids Is Diet-Dependent. Nutrients (2021). PMID 34064336
- Stallings VA et al. Diagnosing malabsorption with systemic lipid profiling: pharmacokinetics of pentadecanoic acid and triheptadecanoic acid following oral administration in healthy subjects and subjects with cystic fibrosis. International journal of clinical pharmacology and therapeutics (2013). PMID 23357842
- Forouhi NG et al. Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study. The lancet. Diabetes & endocrinology (2014). PMID 25107467
- Imamura F et al. Fatty acid biomarkers of dairy fat consumption and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies. PLoS medicine (2018). PMID 30303968
- Brian T. Steffen et al. Plasma pentadecanoic acid is modestly related to cardiovascular health in CARDIA and ARIC cohorts: observational associations without evidence of causality. Frontiers in Nutrition (2026). PMID 41743064
- Sellem L et al. Can individual fatty acids be used as functional biomarkers of dairy fat consumption in relation to cardiometabolic health? A narrative review. The British journal of nutrition (2022). PMID 35086579
- Fatty15 (Seraphina Therapeutics) Fatty15 FAQs. Fatty15 (Seraphina Therapeutics) (2026). source
- Mohammad M. H. Abdullah et al. Recommended dairy product intake modulates circulating fatty acid profile in healthy adults: a multi-centre cross-over study. British Journal Of Nutrition (2015). PMID 25609231
- Miles FL et al. Plasma, Urine, and Adipose Tissue Biomarkers of Dietary Intake Differ Between Vegetarian and Non-Vegetarian Diet Groups in the Adventist Health Study-2. The Journal of nutrition (2019). PMID 30770530
- Cinelli G et al. Association between Maternal and Foetal Erythrocyte Fatty Acid Profiles and Birth Weight. Nutrients (2018). PMID 29570689
- Wang J et al. Pentadecanoic acid (C15:0, PA) induces mild maternal glucose intolerance and promotes the growth of the offspring partly through up-regulating liver PPARα and MAPK signaling pathways. Food & function (2024). PMID 39434548
- Wang C et al. Pentadecanoic acid (C15:0) promotes placental angiogenesis by activating the placental PI3K-AKT signaling. Food & function (2025). PMID 41221667
- Bi Y et al. Odd- and branched-chain fatty acids in breast milk and neurodevelopment in early infancy: a prospective cohort study. European journal of nutrition (2026). PMID 42965676
- Chen X et al. Lipid biomarkers for the prediction of type 2 diabetes risk, an umbrella review and updated meta-analyses of prospective observational studies. Frontiers in endocrinology (2026). PMID 42181198
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.